Endocrine Disruptor Screening Program (EDSP)
ILS is pleased to announce its position as a leading provider of Endocrine Disruptor Screening Program (EDSP) Tier 1 testing services. We offer customized solutions to current and future customers, in accordance with the Clean Water Act as implemented by the US EPA.
ILS, in partnership with Smithers Viscient and CeeTox, provides the only one-stop solution to address the full suite of required endocrine disruptor screening tests. We believe this holistic solution is critical when delivering testing results to the Agency. The series of tests in the endocrine disruptor screening program were designed to be complementary, and executing the studies in the program as a cohesive unit adds value to the customer’s final deliverable. We provide our customers the expertise to make informed predictions and evaluate data in real time to save money and increase efficiency.
Please contact our business development team or our scientific leadership for further information or a free consultation.
Lead Scientist
Susan Borghoff, Ph.D., DABT
Dr. Borghoff joined ILS in 2006 as the Director of the Investigative Toxicology Division and oversees the Biomarkers and Kinetics program. She is an active member of the Society of Toxicology, and she was an Associate Editor for Toxicological Sciences (2003-2008) and served on the editorial board for Chemical Biological Interactions and Toxicology Letters. She has been a Diplomat of the American Board of Toxicology since 1994. Dr. Borghoff has served on review panels and as a working group member for national and international organizations including USEPA, NIEHS, NCI, IPCS, ECETOC, and IARC. In 1994, Dr. Borghoff received the Frank R. Blood Award for the best paper of the year published in one of the Society of Toxicology research journals. In 2000, she received the Society of Toxicology Risk Assessment Specialty Section Award. Dr. Borghoff has over 20 years of experience in study development, design, and management of in vitro and in vivo toxicological studies; she has a broad knowledge of pharmacokinetics and metabolism of specific chemicals as a step in studying the mode-of-action by which they induce a toxic and/or carcinogenic response. Dr. Borghoff received her Ph.D. and MSPH in Environmental Sciences and Engineering from the University of North Carolina at Chapel Hill.